COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
AJR Am J Roentgenol
; 217(4): 857-858, 2021 10.
Article
in English
| MEDLINE | ID: covidwho-1352775
ABSTRACT
The purpose of this article is to report on 23 women with evidence of axillary adenopathy at breast imaging after recent COVID-19 vaccination. A total of 13% of patients had symptoms (axillary lump), 43% were undergoing screening, and 43% were undergoing diagnostic imaging for other reasons. BI-RADS category 2 was assigned in one case, BI-RADS 3 in 21 (ultrasound in 4-24 weeks), and BI-RADS 4 in one. Radiologist familiarity and evidence-based guidelines are needed to avoid follow-up imaging and biopsies for reactive adenopathy after COVID-19 vaccination.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Mammography
/
Ultrasonography, Mammary
/
Lymphadenopathy
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Cohort study
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
English
Journal:
AJR Am J Roentgenol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS